The content is available as a PDF (23.6 KB).
REFERENCES
- 1. Nakamura RM, Bylund DJ. Factors influencing change in the clinical immunology laboratory. Clin Chem 1994;40:2193–2204. Medline [PubMed] [Google Scholar]
- 2. Nakamura RM. Impact of the healthcare revolution and the future role of the clinical immunology laboratory In: Nakamura RM, Burek CL, Cook L, Folds JD, Sever JL, editors. Clinical diagnostic immunology: protocols in quality assurance and standardization. Boston: Blackwell Science; 1998. p 32–40. [Google Scholar]
- 3. Poste G. Molecular medicine and information‐based targeted healthcare. Nat Biotechnol 1998;16:19–21. [DOI] [PubMed] [Google Scholar]
- 4. Back JF. Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin Immunol Immunopathol 1994;72:156–161. Medline [DOI] [PubMed] [Google Scholar]
- 5. Osterland CK. Laboratory diagnosis and monitoring in chronic systemic autoimmune diseases. Clin Chem 1994;40:2146–2153. Medline [PubMed] [Google Scholar]
- 6. Drews J. Biotechnology’s metamorphosis into a drug discovery industry. Nat Biotechnol 1998;16(Suppl):22–24. Medline [DOI] [PubMed] [Google Scholar]
- 7. Haseltine WA. The power of genomics to transform the biotechnology industry. Nat Biotechnol 1998;16(Suppl):25–27. [DOI] [PubMed] [Google Scholar]
- 8. Pickering L. Sequencing the genome. Genetic Engineering News 1998(Oct.);18:18, 4, 51. [Google Scholar]
- 9. Saegusa A. Japan plans economic growth through biotechnology. Nat Biotechnol 1998;16:329–330. [Google Scholar]
- 10. Sainato D. Microchip devices refine future clinical analyzer. Clinical Laboratory News (AACC) 1998;24:22–23. [Google Scholar]
- 11. Dutton G. Miniaturization in genomic screening. Genetic Engineering News 1998(Sept.);18: 12, 29, 30, 34. [Google Scholar]
- 12. Zhang M. Martin KJ, Sheng S, Sager R. Expression genetics: a different approach to cancer diagnosis and prognosis. Trends in Biotechnology (TIBTECH) 998;16:66–71. [DOI] [PubMed] [Google Scholar]
- 13. Vaughan TJ, Williams AJ, Pritchard K, et al. Human antibodies with sub‐nanomolar affinities isolated from a large non‐immunized phage display library. Nat Biotechnol 1996;14:309–314. Medline [DOI] [PubMed] [Google Scholar]
- 14. Vaughan TJ, Osbourn JK, Tempest PR. Human antibodies by design. Nat Biotechnol 1998;16:535–539. Medline [DOI] [PubMed] [Google Scholar]
- 15. Fujii I, Fukuyama S, Iwabuchi Y, Tanimura, R . Evolving catalytic antibodies in a phage‐displayed combinatorial library. Nat Biotechnol 1998;16:463–467. Medline [DOI] [PubMed] [Google Scholar]
- 16. Lee SC. Biotechnology for nanotechnology. TIBTECH 1998;16:239–40. [Google Scholar]
- 17. Davis SS. Biomedical applications of nanotechnology—implications for drug targeting and gene therapy. TIBTECH 1997;15:217–224. [DOI] [PubMed] [Google Scholar]
- 18. Holzman D. Partnership formed to create new biochip. Genetic Engineering News 1998(Aug.)18:1, 8, 47. [Google Scholar]
- 19. Marshall A, Hodgson J. DNA chips: an array of possibilities. Nat Biotechnol 1998;16:27–31. Medline [DOI] [PubMed] [Google Scholar]
- 20. Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW. Microassays: biotechnology’s discovery platform for functional genomics. Trends in Biotechnology (TIBTECH) 1998;16:301–306. [DOI] [PubMed] [Google Scholar]
- 21. Van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? JAMA 1998;280: 550–558. Medline [DOI] [PubMed] [Google Scholar]
- 22. Guyatt GH, Tugwell PX, Feeny DH, et al. A framework for clinical evaluation of diagnostic techniques. Can Med Assoc J 1986;134:587–594. [PMC free article] [PubMed] [Google Scholar]
- 23. Sainato D. Pharmacogenetics—what role in patient care? Clinical Laboratory News (AACC) 1998(Oct.);24:24–25. [Google Scholar]